Search Results - "DeSuza, Kayla R."

Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib by Frankel, Arthur E., Reddy, Renuka, DeSuza, Kayla R., Deeb, Khaled, Carlin, Aaron F., Smith, Davey, Xie, Yushuang, Naik, Eknath, Silver, Richard T., Hasselbalch, Hans C.

“…An 83‐year‐old female had asymptomatic SARS‐CoV‐2 infection while taking ruxolitinib. She remained RT‐PCR positive for viral RNA for >120 days, and Pegylated…”
Get full text

When HIT Testing Hurts- the Financial and Clinical Repercussions of Heparin Induced Thrombocytopenia Testing: A Single Center Analysis by Krishnan, Nithya, Boldig, Kimberly, DeSuza, Kayla R, Miatech, Jennifer, Quan, Walter JR, Stack, Anthony

“…Introduction: Thrombocytopenia is a common inpatient hematologic concern. Most often, thrombocytopenia is a multifactorial phenomenon, without one clear cause…”
Get full text

Activity and Event-Free Survival in Intermediate Grade Non-Hodgkin's Lymphoma Treated with Chemoimmunotherapy Utilizing Single Dose Intravenous Methylprednisolone in Lieu of Oral Prednisone by Quan, Walter JR, Kiamos, Amy, DeSuza, Kayla R, Wiemer, Layton, Daly, Alison, Rogers, Christy, Quan, Francine M

“…Schein et al first noted that patients with intermediate grade lymphoma treated with combination chemotherapy leading to complete response lasting 24 months…”
Get full text

Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib by Frankel, Arthur E, Reddy, Renuka, DeSuza, Kayla R, Deeb, Khaled, Carlin, Aaron F, Smith, Davey, Xie, Yushuang, Naik, Eknath, Silver, Richard T, Hasselbalch, Hans C

“…An 83-year-old female had asymptomatic SARS-CoV-2 infection while taking ruxolitinib. She remained RT-PCR positive for viral RNA for >120 days, and Pegylated…”
Get full text